Please login to the form below

Not currently logged in
From: Research

EMA picks projects for adaptive licensing project

European Medicines Agency (EMA)Begins discussions on how the model will be implemented in practice

From: Sales

Sovaldi dropped by Express Scripts in favour of Viekira Pak

gilead-sciences-sovaldiPharmacy benefits organisation ramps up US pricing pressure on Gilead

From: Sales

BMS cancer drug Opdivo gains US melanoma licence

Bristol-Myers Squibb (BMS) buildingTherapeutic vaccine can now be used against the deadliest form of skin cancer

From: Sales

AbbVie wins key approval for hep C pill Viekira Pak

US regulator Food and Drug Administrator FDAPrices all-oral treatment fractionally lower than rivals from Gilead

Assessing drugs for ultra-rare conditions in the UK

Alexion’s Soliris has become the first drug to pass through NICE’s new highly specialised technology process

darwins medicine

Pharma’s pigeons

If it can adapt, a lucrative new niche is opening up for pharma

Pfizer taps mobile app for patient recruitment

Looks to use smartphone technology to identify rare disease patients

Bone Therapeutics looks to Pfizer for clinical head

Guy Heynen has 35 years of industry experience


Media planning on a global scale

Think international when combining the most appropriate media vehicles and formats for marketing efforts

global scale atom

CRF Health boosts leadership team

John Blakely and Risto Enbuska join the electronic patient reported outcomes firm


US doctors support digital health technology

Mobile devices and apps find favour in new survey

Pharma iPad detailing doctors physicians

Featured jobs

Subscribe to our email news alerts


Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Can Cinderella save us?
The impending threat of antibiotic resistance
Antibiotic Research UK is the BIA's charity of 2015, but what does it intend to do?...
UK life sciences minister George Freeman
Creating a 21st century life sciences ecosystem
The UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation...
Improving Corporate Memory as a Patient Safety Strategy
An article by Lorri Zipperer...